Cited by 845Cancer Mechanisms and TherapyProtein Kinase Regulation and GTPase SignalingMechanisms of cancer metastasis

The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.

Src family kinases in tumor progression and metastasis

Summy, Justin M., Gallick, Gary E.·2003·Cancer and Metastasis Reviews

Open this paper in CoChat — free account

Abstract

The Src family of non-receptor protein tyrosine kinases plays critical roles in a variety of cellular signal transduction pathways, regulating such diverse processes as cell division, motility, adhesion, angiogenesis, and survival. Constitutively activated variants of Src family kinases, including the viral oncoproteins v-Src and v-Yes, are capable of inducing malignant transformation of a variety of cell types. Src family kinases, most notably although not exclusively c-Src, are frequently overexpressed and/or aberrantly activated in a variety of epithelial and non-epithelial cancers. Activation is very common in colorectal and breast cancers, and somewhat less frequent in melanomas, ovarian cancer, gastric cancer, head and neck cancers, pancreatic cancer, lung cancer, brain cancers, and blood cancers. Further, the extent of increased Src family activity often correlates with malignant potential and patient survival. Activation of Src family kinases in human cancers may occur through a variety of mechanisms and is frequently a critical event in tumor progression. Exactly how Src family kinases contribute to individual tumors remains to be defined completely, however they appear to be important for multiple aspects of tumor progression, including proliferation, disruption of cell/cell contacts, migration, invasiveness, resistance to apoptosis, and angiogenesis. This review details the evidence for Src family activation in human tumors, and emphasizes possible consequences to tumor progression. Given the ability of Src and its family members to participate in so many aspects of tumor progression and metastasis, Src family kinases are attractive targets for future anti-cancer therapeutics.

Integrity signals

Registry

Crossref · 10.1023/a:1023772912750

Cites

171 of 171 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
Thomas, S. Μ., & Brugge, J. S. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.513 · Cited by 2,537
Transforming gene product of Rous sarcoma virus phosphorylates tyrosine
Hunter, T. R., & Sefton, B. M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1311 · Cited by 2,333
Three-dimensional structure of the tyrosine kinase c-Src
Xu, W., Harrison, S. C., & Eck, M. J. (1997) · Nature · doi:10.1038/385595a0 · Cited by 1,432
DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA
STEHELIN, D., VARMUS, H. E., BISHOP, J. M., & VOGT, P. K. (1976) · Nature · doi:10.1038/260170a0 · Cited by 1,321 · cited 2×
“Through then very tedious molecular approaches, Bishop and Varmus [3] demonstrated that the viral Src gene (v-src) had as its progenitor a normal cellular gene (proto-oncogene) c-src, an experiment largely responsible for the awarding of the”
Background
Regulation, substrates and functions of src
Brown, M. T., & Cooper, J. A. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00003-0 · Cited by 1,193
Crystal structure of the Src family tyrosine kinase Hck
Sicheri, F., Moarefi, I., & Kuriyan, J. (1997) · Nature · doi:10.1038/385602a0 · Cited by 1,171
A SARCOMA OF THE FOWL TRANSMISSIBLE BY AN AGENT SEPARABLE FROM THE TUMOR CELLS
Rous, P. (1911) · Journal of Experimental Medicine · doi:10.1084/jem.13.4.397 · Cited by 1,051
Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells.
Migliaccio, A., Domenico, M. D., Castoria, G., de Falco, A., Bontempo, P., Nola, E., & Auricchio, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00471.x · Cited by 950
Identification of a transformation-specific antigen induced by an avian sarcoma virus
Brugge, J. S., & Erikson, R. L. (1977) · Nature · doi:10.1038/269346a0 · Cited by 889
Role of Src expression and activation in human cancer
Irby, R., & Yeatman, T. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203912 · Cited by 878

Show all 171 references

Sorted by citations

A renaissance for SRC
Yeatman, T. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1366 · Cited by 1,113
Src signaling in cancer invasion
Guarino, M. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22011 · Cited by 427
Action of the Src Family Kinase Inhibitor, Dasatinib (BMS-354825), on Human Prostate Cancer Cells
Nam, S., Kim, D., Cheng, J. Q., Zhang, S., Lee, J., Buettner, R., Mirosevich, J., Lee, F. Y., & Jove, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1731 · Cited by 377
HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas
Gray, M. J., Zhang, J., Ellis, L. M., Semenza, G. L., Evans, D. B., Watowich, S. S., & Gallick, G. E. (2005) · Oncogene · doi:10.1038/sj.onc.1208513 · Cited by 378
Self-citation
Newest findings on the oldest oncogene; how activated src does it
Frame, M. C. (2004) · Journal of Cell Science · doi:10.1242/jcs.01111 · Cited by 372
Regulation of actin-based cell migration by cAMP/PKA
Howe, A. K. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.03.005 · Cited by 329
Alternative Activation of STAT1 and STAT3 in Response to Interferon-γ
Qing, Y., & Stark, G. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406413200 · Cited by 322
Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis
Julien, S. G., Dubé, N., Read, M., Penney, J. E., Paquet, M., Han, Y., Kennedy, B. P., Muller, W. J., & Tremblay, M. L. (2007) · Nature Genetics · doi:10.1038/ng1963 · Cited by 313
An integrin αvβ3–c-Src oncogenic unit promotes anchorage-independence and tumor progression
Desgrosellier, J. S., Barnes, L. A., Shields, D. J., Huang, M., Lau, S. K., Prévost, N., Tarin, D., Shattil, S. J., & Cheresh, D. A. (2009) · Nature Medicine · doi:10.1038/nm.2009 · Cited by 293
Epithelial mesenchymal transition (EMT): a universal process in lung diseases with implications for cystic fibrosis pathophysiology
Rout-Pitt, N., Farrow, N., Parsons, D., & Donnelley, M. (2018) · Respiratory Research · doi:10.1186/s12931-018-0834-8 · Cited by 280
Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells
Hiscox, S., Morgan, L. D., Green, T. P., Barrow, D., Gee, J. M. W., & Nicholson, R. I. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9120-9 · Cited by 275
Targeting Src in breast cancer
Finn, R. S. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn291 · Cited by 251
Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
Green, T. P., Fennell, M., Whittaker, R., Curwen, J., Jacobs, V., Allen, J., Logie, A., Hargreaves, J., Hickinson, D. M., Wilkinson, R. W., et al. (2009) · Molecular Oncology · doi:10.1016/j.molonc.2009.01.002 · Cited by 238
Targeting Src Family Kinases Inhibits Growth and Lymph Node Metastases of Prostate Cancer in an Orthotopic Nude Mouse Model
Park, S. I., Zhang, J., Phillips, K. A., Araujo, J. C., Najjar, A. M., Volgin, A. Y., Gelovani, J. G., Kim, S., Wang, Z., & Gallick, G. E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2997 · Cited by 233
Self-citation
Regulation of Src Family Kinases in Human Cancers
Sen, B., & Johnson, F. M. (2011) · Journal of Signal Transduction · doi:10.1155/2011/865819 · Cited by 235
Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer
Moghaddam, S. M., Amini, A., Morris, D. L., & Pourgholami, M. H. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9337-5 · Cited by 243
Treatment for Advanced Tumors: Src Reclaims Center Stage
Summy, J. M., & Gallick, G. E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2692 · Cited by 224
Self-citation
Invadopodia: At the cutting edge of tumour invasion
Stylli, S. S., Kaye, A. H., & Lock, P. (2008) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2008.03.003 · Cited by 226
Post-translational myristoylation: Fat matters in cellular life and death
Martin, D. D. O., Beauchamp, E., & Berthiaume, L. G. (2010) · Biochimie · doi:10.1016/j.biochi.2010.10.018 · Cited by 225
Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer
Yu, E. Y., Wilding, G., Posadas, E. M., Gross, M. E., Culine, S., Massard, C., Morris, M. J., Hudes, G. R., Calabrò, F., Cheng, S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1691 · Cited by 219
Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion
Bourguignon, L., Wong, G., Earle, C. A., Krueger, K., & Spevak, C. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.162305 · Cited by 213
Overexpression of the Cell Adhesion Molecules DDR1, Claudin 3, and Ep-CAM in Metaplastic Ovarian Epithelium and Ovarian Cancer
Heinzelmann-Schwarz, V. A., Gardiner‐Garden, M., Henshall, S. M., Scurry, J., Scolyer, R. A., Davies, M. J., Heinzelmann, M., Kalish, L. H., Bali, A., Kench, J. G., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0073 · Cited by 209
Inhibition of Src Expression and Activity Inhibits Tumor Progression and Metastasis of Human Pancreatic Adenocarcinoma Cells in an Orthotopic Nude Mouse Model
Trevino, J. G., Summy, J. M., Lesslie, D. P., Parikh, N. U., Hong, D. S., Lee, F. Y., Donato, N. J., Abbruzzese, J. L., Baker, C. H., & Gallick, G. E. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050570 · Cited by 206
Self-citation
The Role of Lysyl Oxidase in SRC-Dependent Proliferation and Metastasis of Colorectal Cancer
Baker, A., Cox, T. R., Bird, D., Lang, G., Murray, G. I., Sun, X., Southall, S. M., Wilson, J. R., & Erler, J. T. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq569 · Cited by 206
Src kinase phosphorylates Caspase‐8 on Tyr380: a novel mechanism of apoptosis suppression
Cursi, S., Rufini, A., Stagni, V., Condò, I., Matafora, V., Bachi, A., Bonifazi, A. P., Coppola, L., Superti‐Furga, G., Testi, R., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601085 · Cited by 216
Curcumin Modulates MicroRNA-203–Mediated Regulation of the Src-Akt Axis in Bladder Cancer
Saini, S., Arora, S., Majid, S., Shahryari, V., Chen, Y., Deng, G., Yamamura, S., Ueno, K., & Dahiya, R. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0267 · Cited by 204
The dual kinase complex FAK-Src as a promising therapeutic target in cancer
Bolós, V. (2010) · OncoTargets and Therapy · doi:10.2147/ott.s6909 · Cited by 210
An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold
Cherukupalli, S., Karpoormath, R. V., Chandrasekaran, B., Hampannavar, G. A., Thapliyal, N. B., & Palakollu, V. N. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.11.019 · Cited by 201
Invading one step at a time: the role of invadopodia in tumor metastasis
Paz, H., Pathak, N., & Yang, J. (2013) · Oncogene · doi:10.1038/onc.2013.393 · Cited by 208
Advances in Targeting Src in the Treatment of Breast Cancer and Other Solid Malignancies
Mayer, E. L., & Krop, I. E. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1834 · Cited by 197
Cancer Drug Discovery and Development
Humphrey, J. S., Price, K., Gupta, E., Baxter, A. R. W., Bird, J., Sonnichsen, D. S., & Naglich, J. G. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-325-5_21 · Cited by 195
Steps in prostate cancer progression that lead to bone metastasis
Jin, J., Dayyani, F., & Gallick, G. E. (2011) · International Journal of Cancer · doi:10.1002/ijc.26024 · Cited by 195
Self-citation
The role of Src in prostate cancer
Fizazi, K. S. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm086 · Cited by 184
p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients
Siu, M. K. Y., Chan, H. Y., Kong, D. S. H., Wong, E. S. Y., Wong, O. G., Ngan, H., Tam, K., Zhang, H., Li, Z., Chan, Q. K. Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907481107 · Cited by 180
Targeting of erbB3 receptor to overcome resistance in cancer treatment
Ma, J., Lyu, H., Huang, J., & Liu, B. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-105 · Cited by 176
Src and focal adhesion kinase as therapeutic targets in cancer.
Brunton, V., & Frame, M. (2008) · Current opinion in pharmacology (Print) · doi:10.1016/j.coph.2008.06.012 · Cited by 183
Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells
Pichot, C. S., Hartig, S. M., Xia, L., Arvanitis, C., Monisvais, D., Lee, F. Y., Frost, J. A., & Corey, S. J. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605101 · Cited by 179
SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells
Vultur, A., Buettner, R., Kowolik, C., Liang, W., Smith, D. D., Boschelli, F., & Jove, R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0126 · Cited by 160
SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis
Lamar, J. M., Xiao, Y., Norton, E., Jiang, Z.-G., Gerhard, G. M., Kooner, S., Warren, J. S. A., & Hynes, R. O. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004364 · Cited by 169
Cell adhesion receptors, tyrosine kinases and actin modulators: a complex three-way circuitry
Brunton, V. G., Macpherson, I. R., & Frame, M. C. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.04.010 · Cited by 170
YAP/TAZ Activation as a Target for Treating Metastatic Cancer
Warren, J., Xiao, Y., & Lamar, J. M. (2018) · Cancers · doi:10.3390/cancers10040115 · Cited by 175
SRC gene expression in human cancer: the role of transcriptional activation
Dehm, S. M., & Bonham, K. (2004) · Biochemistry and Cell Biology · doi:10.1139/o03-077 · Cited by 169
IBD Candidate Genes and Intestinal Barrier Regulation
McCole, D. F. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000090 · Cited by 171
Targeting cancer by binding iron: Dissecting cellular signaling pathways
Lui, G. Y. L., Kovačević, Ž., Richardson, V., Merlot, A. M., Kalinowski, D. S., & Richardson, D. R. (2015) · Oncotarget · doi:10.18632/oncotarget.4349 · Cited by 165
Phase II Trial of Saracatinib (AZD0530), an Oral SRC-inhibitor for the Treatment of Patients with Hormone Receptor-negative Metastatic Breast Cancer
Gucalp, A., Sparano, J. A., Caravelli, J. F., Santamauro, J. T., Patil, S. N., Abbruzzi, A., Pellegrino, C. M., Bromberg, J., Dang, C. T., Theodoulou, M., et al. (2011) · Clinical Breast Cancer · doi:10.1016/j.clbc.2011.03.021 · Cited by 159
Current status of SRC inhibitors in solid tumor malignancies
Puls, L. N., Eadens, M., & Messersmith, W. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0408 · Cited by 158
Reactive oxygen species (ROS) in cancer pathogenesis and therapy: An update on the role of ROS in anticancer action of benzophenanthridine alkaloids
Khan, A. Q., Rashid, K., AlAmodi, A. A., Agha, M. V., Akhtar, S., Hakeem, I., Raza, S. S., & Shahab Uddin, M. S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112142 · Cited by 164
Phase I dose-escalation and pharmacokinetic study of dasatinib in patients with advanced solid tumors
Demetri, G. D., Lo Russo, P., MacPherson, I. R. J., Wang, D., Morgan, J. A., Brunton, V. G., Paliwal, P., Agrawal, S., Voi, M., & Evans, T. R. J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0224 · Cited by 150
LYN Is a Mediator of Epithelial-Mesenchymal Transition and a Target of Dasatinib in Breast Cancer
Choi, Y., Bocanegra, M. C., Kwon, M. J., Shin, Y. K., Nam, S. J., Yang, J., Kao, J., Godwin, A. K., & Pollack, J. R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3141 · Cited by 151
Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition
WILSON, C. A., Nicholes, K., Bustos, D. J., Lin, E., Song, Q., Stéphan, J.-P., Kirkpatrick, D. S., & Settleman, J. (2014) · Oncotarget · doi:10.18632/oncotarget.2397 · Cited by 149
Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy
Soltan, O. M., Shoman, M. E., Abdel‐Aziz, S. A., Narumi, A., Konno, H., & Abdel‐Aziz, M. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113768 · Cited by 150
The Src Family of Tyrosine Kinases Is Important for Embryonic Stem Cell Self-renewal
Annerén, C., Cowan, C. A., & Melton, D. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403547200 · Cited by 140
Src Family Kinases as Therapeutic Targets in Advanced Solid Tumors: What We Have Learned So Far
Martellucci, S., Clementi, L., Sabetta, S., Mattei, V., Botta, L., & Angelucci, A. (2020) · Cancers · doi:10.3390/cancers12061448 · Cited by 139
Specific Cross-talk between Epidermal Growth Factor Receptor and Integrin αvβ5 Promotes Carcinoma Cell Invasion and Metastasis
Ricono, J. M., Huang, M., Barnes, L. A., Lau, S. K. M., Weis, S. M., Schlaepfer, D. D., Hanks, S. K., & Cheresh, D. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3612 · Cited by 138
MicroRNA-205 Inhibits Src-Mediated Oncogenic Pathways in Renal Cancer
Majid, S., Saini, S., Dar, A. A., Hirata, H., Shahryari, V., Tanaka, Y., Yamamura, S., Ueno, K., Zaman, M. S., Singh, K., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3666 · Cited by 135
Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab
Dunn, E. F., Iida, M., Myers, R. A., Campbell, D. A., Hintz, K. A., Armstrong, E. A., Li, C., & Wheeler, D. L. (2011) · Oncogene · doi:10.1038/onc.2010.430 · Cited by 133
SKI-606, a Src/Abl Inhibitor with In vivo Activity in Colon Tumor Xenograft Models
Golas, J. M., Lucas, J., Etienne, C., Golas, J., Discafani, C., Sridharan, L., Boghaert, E., Arndt, K., Ye, F., Boschelli, D. H., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2484 · Cited by 134
Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products
Siveen, K. S., Prabhu, K. S., Achkar, I. W., Kuttikrishnan, S., Shyam, S., Khan, A. Q., Merhi, M., Dermime, S., & Shahab Uddin, M. S. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0788-y · Cited by 137
The Involvement of the Tyrosine Kinase c-Src in the Regulation of Reactive Oxygen Species Generation Mediated by NADPH Oxidase-1
Gianni, D., Bohl, B. P., Courtneidge, S. A., & Bokoch, G. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-02-0138 · Cited by 132
The Role of Vinculin in the Regulation of the Mechanical Properties of Cells
Mierke, C. T. (2009) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-009-9047-6 · Cited by 131
Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma
Milano, V., Piao, Y., LaFortune, T. A., & de Groot, J. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0669 · Cited by 126
EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment
Keller, S., & Schmidt, M. H. H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061295 · Cited by 130
Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases
Lesslie, D. P., Summy, J. M., Parikh, N. U., Fan, F., Trevino, J., Sawyer, T. K., Metcalf, C. A., Shakespeare, W. C., Hicklin, D. J., Ellis, L. M., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603143 · Cited by 126
Self-citation
c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis
Zhang, J., Wang, S., Jiang, B., Huang, L., Ji, Z., Li, X., Zhou, H.-M., Han, A., Chen, A., Wu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms13732 · Cited by 125
Understanding the biology of HER3 receptor as a therapeutic target in human cancer
Lyu, H., Han, A., Polsdofer, E., Liu, S., & Liu, B. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.05.010 · Cited by 125
Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib
Serrels, A., Macpherson, I. R., Evans, T. R. J., Lee, F. Y., Clark, E. A., Sansom, O. J., Ashton, G. H. S., Frame, M. C., & Brunton, V. G. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0382 · Cited by 126
Inhibition of Src Family Kinases with Dasatinib Blocks Migration and Invasion of Human Melanoma Cells
Buettner, R., Mesa, T., Vultur, A., Lee, F., & Jove, R. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0169 · Cited by 122
Two N-Myristoyltransferase Isozymes Play Unique Roles in Protein Myristoylation, Proliferation, and Apoptosis
Ducker, C., Upson, J., French, K., & Smith, C. D. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0037 · Cited by 121
Crk-Associated Substrate Tyrosine Phosphorylation Sites Are Critical for Invasion and Metastasis of Src-Transformed Cells
Brábek, J., Constancio, S. S., Siesser, P. F., Shin, N.-Y., Pozzi, A., & Hanks, S. K. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0015 · Cited by 119
Modeling tumor invasion and metastasis in Drosophila
Miles, W. O., Dyson, N., & Walker, J. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.006908 · Cited by 128
CUB Domain-Containing Protein 1 Is a Novel Regulator of Anoikis Resistance in Lung Adenocarcinoma
Uekita, T., Jia, L., Narisawa‐Saito, M., Yokota, J., Kiyono, T., & Sakai, R. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01246-07 · Cited by 119
Involvement of Src Family Kinases in N-Cadherin Phosphorylation and β-Catenin Dissociation during Transendothelial Migration of Melanoma Cells
Qi, J., Wang, J., Romanyuk, O., & Siu, C. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-10-0927 · Cited by 115
Quantitative Phosphoproteomics Reveals a Cluster of Tyrosine Kinases That Mediates Src Invasive Activity in Advanced Colon Carcinoma Cells
Leroy, C., Fialin, C., Sirvent, A., Simon, V., Urbach, S., Poncet, J., Robert, B., Jouin, P., & Roche, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2354 · Cited by 114
Progress towards the development of SH2 domain inhibitors
Kraskouskaya, D., Duodu, E., Arpin, C. C., & Gunning, P. T. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35449k · Cited by 115
MicroRNA-218 Is Deleted and Downregulated in Lung Squamous Cell Carcinoma
Davidson, M. R., Larsen, J. E., Yang, I. A., Hayward, N. K., Clarke, B. E., Duhig, E., Passmore, L. H., Bowman, R., & Fong, K. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012560 · Cited by 116
Curcumin enhances dasatinib‐induced inhibition of growth and transformation of colon cancer cells
Nautiyal, J., Banerjee, S., Kanwar, S. S., Yu, Y., Patel, B. B., Sarkar, F. H., & Majumdar, A. P. N. (2010) · International Journal of Cancer · doi:10.1002/ijc.25410 · Cited by 113
c-Src–Mediated Phosphorylation of NoxA1 and Tks4 Induces the Reactive Oxygen Species (ROS)–Dependent Formation of Functional Invadopodia in Human Colon Cancer Cells
Gianni, D., Taulet, N., DerMardirossian, C. M., & Bokoch, G. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-08-0685 · Cited by 112
Cdc42 Interacting Protein 4 promotes breast cancer cell invasion and formation of invadopodia through activation of N-WASp
Pichot, C., Arvanitis, C., Hartig, S. M., Jensen, S., Bechill, J., Marzouk, S., Yu, J.-D., Frost, J., & Corey, S. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4149 · Cited by 6
Src continues aging: current and future clinical directions
Kopetz, S., Shah, A. N., & Gallick, G. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1902 · Cited by 111
Self-citation
Targeted Inhibition of Src Kinase with Dasatinib Blocks Thyroid Cancer Growth and Metastasis
Chan, C. M., Jing, X., Pike, L. A., Zhou, Q., Lim, D., Sams, S. B., Lund, G. S., Sharma, V., Haugen, B. R., & Schweppe, R. E. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3359 · Cited by 113
Lyn Kinase Activity Is the Predominant Cellular Src Kinase Activity in Glioblastoma Tumor Cells
Stettner, M. R., Wang, W., Nabors, B., Bharara, S., Flynn, D. C., Grammer, J. R., Gillespie, G. Y., & Gladson, C. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3688 · Cited by 111
Emerging molecular targets in melanoma invasion and metastasis
Orgaz, J. L., & Sanz‐Moreno, V. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12041 · Cited by 113
Future directions of bone-targeted therapy for metastatic breast cancer
Onishi, T., Hayashi, N., Theriault, R. L., Hortobágyi, G. N., & Ueno, N. T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.134 · Cited by 110
Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration
Yadav, V., & Denning, M. F. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20716 · Cited by 109
Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial
Hannon, R. A., Clack, G., Rimmer, M., Swaisland, A. J., Lockton, J. A., Finkelman, R. D., & Eastell, R. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090830 · Cited by 110
Potential role of N-myristoyltransferase in cancer
Selvakumar, P., Lakshmikuttyamma, A., Shrivastav, A., Das, S. B., Dimmock, J. R., & Sharma, R. K. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2006.05.002 · Cited by 113
Novel p47 phox -Related Organizers Regulate Localized NADPH Oxidase 1 (Nox1) Activity
Gianni, D., Díaz, B., Taulet, N., Fowler, B. J., Courtneidge, S. A., & Bokoch, G. (2009) · Science Signaling · doi:10.1126/scisignal.2000370 · Cited by 110
miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1
Cao, M., Hou, D., Liang, H., Gong, F., Wang, Y., Yan, X., Jiang, X., Wang, C., Zhang, J., Zen, K., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2013.12.024 · Cited by 110
Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer
Kim, M. S., Lee, W. S., Jeong, J., Kim, S., & Jin, W. (2015) · Oncotarget · doi:10.18632/oncotarget.5522 · Cited by 108
Endocytosis and cancer
Polo, S., Pece, S., & Fiore, P. P. D. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.02.003 · Cited by 107
ErbB2 Promotes Src Synthesis and Stability: Novel Mechanisms of Src Activation That Confer Breast Cancer Metastasis
Tan, M., Li, P., Klos, K. S., Lü, J., Lan, K., Nagata, Y., Fang, D., Jing, T., & Yu, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2353 · Cited by 107
KLF8 transcription factor participates in oncogenic transformation
Wang, X., & Zhao, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209796 · Cited by 106
Age-Specific Differences in Oncogenic Pathway Deregulation Seen in Human Breast Tumors
Anders, C. K., Acharya, C. R., Hsu, D. S., Broadwater, G., Garman, K. S., Foekens, J. A., Zhang, Y., Wang, Y., Marcom, K., Marks, J. R., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001373 · Cited by 106
Src signaling pathways in prostate cancer
Varkaris, A. S., Κατσιαμπούρα, Α., Araujo, J. C., Gallick, G. E., & Corn, P. G. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9481-1 · Cited by 109
Self-citation
The role of Src in solid and hematologic malignancies
Álvarez, R. H., Kantarjian, H. M., & Cortes, J. E. (2006) · Cancer · doi:10.1002/cncr.22215 · Cited by 105
Synthesis of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates and evaluation of their Src kinase inhibitory and anticancer activities
Kumar, A., Ahmad, I., Chhikara, B. S., Tiwari, R. K., Mandal, D., & Parang, K. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.047 · Cited by 104
Targeted Inhibition of Src Kinase Signaling Attenuates Pancreatic Tumorigenesis
Nagathihalli, N. S., Smith, J. J., Revetta, F. L., Washington, M. K., & Merchant, N. B. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1212 · Cited by 103
Upregulation and activation of PKCα by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKCα and Src inhibitors
Tan, M., Li, P., Sun, M.-E., Yin, G., & Yu, D.-H. (2006) · Oncogene · doi:10.1038/sj.onc.1209361 · Cited by 114
Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
Konecny, G. E., Glas, R., Dering, J., Manivong, K., Qi, J., Finn, R. S., Yang, G. R., Hong, K.-L., Ginther, C., Winterhoff, B. J. N., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605381 · Cited by 104
Protein Kinase Cα Activates c-Src and Induces Podosome Formation via AFAP-110
Gatesman, A., Walker, V. G., Baisden, J. M., Weed, S. A., & Flynn, D. C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7578-7597.2004 · Cited by 101

Authors: Summy, J. M., & Gallick, G. E.
Affiliations: The University of Texas MD Anderson Cancer Center (US)
Corresponding author: Gallick, Gary E.
Venue: Cancer and Metastasis Reviews
Publisher: Springer Science and Business Media LLC
Published: 2003-12
Volume: 22
Issue: 4
Pages: 337-358
ISSN: 0167-7659 (ISSN-L)
1573-7233
DOI: 10.1023/a:1023772912750
OpenAlex: W1589166971
Cited by: 827
References: 171
Citations by year: 2026: 15 · 2025: 15 · 2024: 17 · 2023: 17 · 2022: 26 · 2021: 27 · 2020: 26 · 2019: 35 · 2018: 32 · 2017: 28 · 2016: 32 · 2015: 37 · 2014: 64 · 2013: 55 · 2012: 49
FWCI: 4.32
Type: journal article
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Cancer and Metastasis Reviews (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ca065527-07)
National Cancer Institute (U54CA090810, 2 R01 CA65527)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
Keywords: Src family kinases, Src kinase, non-receptor tyrosine kinase, tumor progression, metastasis, constitutive kinase activation, v-Src, malignant transformation, cell migration and invasion, angiogenesis, apoptosis resistance, cancer therapeutics, colorectal cancer, breast cancer, melanoma, lung cancer
MeSH terms: Enzyme Activation, Humans, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Signal Transduction, Disease Progression, src-Family Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Src family kinases in tumor progression and metastasis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks